Neuroendocrine Influences on Mammary Cancer

Hill, Steven M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA054152-05
• Application #: 2095702
• Study Section: Metabolic Pathology Study Section (MEP)
• Project Start: 1991-04-01
• Project End: 1996-12-31
• Budget Start: 1995-04-28
• Budget End: 1996-12-31
• Support Year: 5
• Fiscal Year: 1995

Institution

• Name: Tulane University
• Department: Anatomy/Cell Biology
• Type: Schools of Medicine
• City: New Orleans
• State: LA
• Country: United States
• Zip Code: 70118

Publications

Hill, Steven M; Cheng, Chi; Yuan, Lin et al. (2013) Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth. Curr Aging Sci 6:125-33

Xiang, Shulin; Mao, Lulu; Yuan, Lin et al. (2012) Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ER?, Akt1, and Stat5. J Pineal Res 53:307-18

Hill, Steven M; Cheng, Chi; Yuan, Lin et al. (2011) Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res Treat 127:91-8

Lai, Ling; Yuan, Lin; Cheng, Qi et al. (2009) Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat 118:293-305

Hill, Steven M; Frasch, Tripp; Xiang, Shulin et al. (2009) Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 8:337-46